查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1200897

日本医院用品市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Japan Hospital Supplies Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 70 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，日本医院用品市场的复合年增长率预计为 6.9%。

COVID-19 在早期阶段对日本医院用品市场和整个医疗行业产生了重大影响，大量患者激增导致医院设备、针头和注射器短缺。稻田。 例如，根据 NPR 2021 年 2 月的一份报告，日本很难获得特殊的注射器，以最大限度地增加每个小瓶中使用的 COVID-19 疫苗的注射次数。 有人担心，即使製造商急于提高产量，也会有数百万剂疫苗被浪费掉。 然而，在大流行后的情况下，市场正在扩大，未来几年可能会进一步增长。 支持医院用品需求的是流行病后日本流行的传染病、院内感染、手术部位感染等的增加。

合併感染疾病的发病率不断上升以及公众对这种情况的认识不断提高等因素预计将推动日本医院用品市场的扩张。 例如，根据 2022 年 1 月发表的 Plos One 论文，流行性感冒、咽结膜热、A 组链球菌咽炎、水痘、传染性红斑、流行性角结膜炎、肺炎支原体和百日咳在 COVID-19 之前在日本流行。 此外，预计在预测期内，日本与医院用品相关的竞争对手、产品发布和合作的存在将推动市场增长。 同样，2021年9月，外交部在台北市上演的10,000台脉搏血氧仪和1,008台氧气浓缩器将捐赠日本，彰显政府支持东亚国家稻田的承诺。 此外，随着人口老龄化加剧，医院供应市场的需求也在增加。 老年人更容易感染和患病，这有望对日本医院用品市场产生积极影响。 例如，根据日本统计局的数据，2021年老年人口（65岁及以上）将达到3621万人，占总人口的28.9%（即四分之一），创历史新高。

由于传染病数量的增加和医疗基础设施的迅速扩张，日本医院用品市场在预测期内可能会增长。 然而，许可当局的严格监管和家庭护理服务的出现正在抑制市场增长。

日本医院产品的市场动向

灭菌器和消毒剂市场有望在预测期内实现高速增长

消毒是从无生命物体或表面去除或减少有害微生物的过程。 灭菌会杀死所有微生物并破坏存在于表面、液体、药物或化合物（例如生物介质）上的各种生物体的孢子。

医院需要灭菌和消毒产品来防止医院获得性感染 (HAI) 等疾病的传播。 老年人也更容易患慢性病。 因此，日本越来越多的老年人患有慢性病，这将导致住院人数增加。 例如，根据日本统计局 2022 年更新，2060 年 65 岁及以上人口的年龄分布构成估计为 38.1%。 此外，根据2022年6月在Hindawi发表的一篇论文，上海1485家住院三级医院的病历发现，与院内感染相比，大多数患者是院内感染。我来了。 因此，由于日本的院内感染率很高，预计该市场在未来几年将会增长。

此外，与消毒和灭菌行业相关的政府举措和资金预计将在预测期内推动市场增长。 例如，2022 年 7 月，日本政府向 GARDP 提供额外资金，以支持其在开发耐药感染新疗法方面的重要工作。 这笔预算预计将支持 GARDP 在院内感染、性传播感染和新生儿感染治疗方面的开发工作。 从 2022 年 4 月到 2023 年 3 月，日本已向 GARDP 捐款超过 180 万美元。 此外，主要参与者正在实施产品发布、併购等战略计划，以在预测期内促进市场增长。 例如，2021年1月，IKEUCHI推出了一款新型雾化装置“Dry-Fog HIGHNOW (DFH)”，可以快速、轻鬆、有效地进行消毒。 这是一种背包式消毒装置，使用池内专利的特殊喷嘴喷出平均液滴尺寸为10μm或更小的“干雾”消毒剂。 传统的喷雾器产生的雾滴粗大，因此通过用DFH喷洒消毒剂，现在可以确保消毒剂到达甚至难以到达的小缝隙和盲点。

因此，由于医院获得性感染的增加、老年人口的增加、消毒产品的推出激增等，预计该行业在预测期内将会增长。

在预测期内，日本医院用品市场的注射器和针头细分市场预计将显着增长

由于需要接种疫苗的传染病增加、医疗成本上升以及产品发布增加等因素，预计日本医院供应市场的注射器和针头将会增长。 例如，根据 NIID Japan 2022 监测更新，2022 年东京报告的结核病例累计为 1,738 例。 传染病的增加将在预测期内推动注射器和针头部分的增长，因为疫苗接种的需求将会增加。

此外，预计在预测期内，针头和注射器销售和收购方面的产品发布、合作和伙伴关係将推动市场增长。 例如，2021 年 3 月，Terumo Corporation 开发了一种注射器，可从 COVID-19 疫苗瓶中抽取 7 针，而现有註射器为 5 针。 此外，预计研究区域增加免疫接种和疫苗接种将推动注射器和针头市场的增长。 例如，根据 Our World In Data 2022 年 10 月更新，到 2021 年，日本 95% 的 1 岁以下儿童将接种 BCG 疫苗。

因此，由于传染病数量的增加以及疫苗接种和疫苗接种计划的增加，预计注射器和针头部分在预测期内将出现市场增长。

日本医院供应市场的竞争对手分析

日本医院用品市场分散，多家公司在全球和本地开展业务。 日本是发达国家，与其他发达国家也有贸易往来。 因此，世界上大多数公司都进入了日本医院用品市场。 此外，一些日本本土企业也在医院用品市场占有一席之地。 其他全球公司也在提高医院用品在日本市场的竞争力。 主要参与者包括 3M、Medtronic、Cardinal Health、Boston Scientific Corporation 和 B. Brown SE。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 不断增长的老年人口和不断增加的传染病发病率
    • 医疗保健基础设施的快速扩张
  • 市场製约因素
    • 严格的监管框架
    • 家庭护理服务的出现
  • 波特的五力分析
    • 供应商的议价能力
    • 买方/消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按类型
    • 体检设备
    • 手术室设备
    • 移动支持和运输设备
    • 灭菌和消毒用品
    • 医院一次性用品
    • 注射器/针头
    • 其他类型

第六章竞争格局

  • 公司简介
    • 3M
    • B. Braun SE
    • Baxter International
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic
    • GE Healthcare
    • Johnson & Johnson
    • Thermo Fisher Scientific

第7章 市场机会今后动向

简介目录
Product Code: 54156

The Japan hospital supplies market is expected to register a CAGR of 6.9% over the forecast period.

COVID-19 significantly impacted the hospital supplies market and the entire healthcare industry in Japan during the initial phases, as the shortage of hospital devices, needles, and syringes led to a problematic situation due to the upsurge of the large patient pool. For instance, as per the February 2021 report by NPR, Japan struggled to obtain special syringes to maximize the number of COVID-19 vaccine shots used from each vial. Even though manufacturers strained to ramp up production rapidly, it still prompts concerns that millions of doses might go to waste. However, in the post-pandemic situation, the market is growing and likely to witness more growth in the coming years. The demand for hospital supplies is supported by increased infectious diseases, hospital-acquired infections, and surgical site infections prevalent in Japan in the post-pandemic era.

The factors, such as increased incidences of communal diseases and growing public awareness about the conditions, will likely increase the Japan hospital supplies market. For instance, according to a Plos One article published in January 2022, influenza, pharyngoconjunctival fever, group A streptococcal pharyngitis, chicken pox, erythema infectiosum, epidemic keratoconjunctivitis, Mycoplasma pneumoniae pneumonia, and pertussis, showed an epidemic in Japan before COVID-19. Furthermore, the presence of competitors, product launches, and collaboration in Japan relating to hospital supplies will likely boost market growth over the forecast period. Similarly, in September 2021, 10,000 pulse oximeters and 1,008 oxygen concentrators were donated to Japan which was staged by the Ministry of Foreign Affairs in Taipei City, underscoring the government's commitment to helping the East Asian country. The hospital supply market demand is also rising due to the increasing geriatric population. As the geriatric population is more prone to infection and diseases, this factor is expected to positively impact Japan's hospital supplies market. For instance, as per the Statistics Bureau of Japan, in 2021, the aged population (65 years old and over) was 36.21 million, constituting 28.9% of the total population (i.e., 1 in every four persons) and marking a high record.

Hence, due to the rise in infectious diseases and rapid expansion of healthcare infrastructure, Japan's hospital supplies market is likely to witness growth over the forecast period. However, stringent regulations by approval authorities and the emergence of homecare services have been restraining the market growth.

Japan Hospital Supplies Market Trends

Sterilization and Disinfectant Products Segment is Expected to Register High Growth in the Forecast Period

Disinfection is the process of eliminating or reducing harmful microorganisms from inanimate objects and surfaces. Sterilization kills all microorganisms, destroying the spores of various organisms on surfaces, in liquids, in medication, or in compounds such as biological culture media.

Sterilization and disinfectant products are necessary for hospitals to prevent the spreading of diseases like hospital-acquired infections (HAI). In addition, the geriatric population is more prone to chronic diseases. Thus, Japan's rising geriatric population that acquires chronic diseases leads to increased hospital admissions. For instance, according to the Japan Statistics Bureau 2022 update, the composition of age distribution above 65 is estimated to be 38.1% by 2060. Moreover, as per the article published in June 2022 in Hindawi, the medical records of the 1,485 hospitalized patients in a tertiary Hospital in Shanghai showed that most of the patients were affected with hospital-acquired infections compared to nosocomial diseases. Hence, the market will likely witness growth in the coming years due to Japan's high prevalence of hospital-acquired infections.

Furthermore, government initiatives and funding relating to the disinfection and sterilization field are anticipated to boost market growth over the forecast period. For instance, in July 2022, the Government of Japan granted additional funding to the GARDP to support its vital work in developing new treatments for drug-resistant infections. The budget is anticipated to support GARDP's work in developing treatments for hospital-acquired infections, sexually transmitted infections, and infections in newborns. Japan provided over USD 1.8 million in funding to GARDP from April 2022 to March 2023. Additionally, key players are implementing strategic plans such as product launches, mergers, and acquisitions to boost market growth over the forecast period. For instance, in January 2021, IKEUCHI launched a new fogging device named Dry-Fog HIGHNOW (DFH) for quick, easy, and effective disinfection. It is a backpack-type disinfection device that sprays a disinfectant solution, "Dry Fog," with a mean droplet size of 10 µm or less using a special nozzle patented by IKEUCHI. Unlike conventional sprayers that produce coarse droplets, spraying a disinfectant solution using DFH makes it possible to thoroughly apply the disinfectant to hard-to-reach small gaps and blind spots.

Thus, due to the rise in hospital-acquired infections, the increase in the geriatric population, and the surge in disinfection product launches, the segment studied is anticipated to witness growth over the forecast period.

Syringes and Needles Segment is Anticipated to Witness a Notable Growth in the Japan Hospital Supplies Market Over the Forecast Period

The syringes and needles segment is anticipated to witness growth in the Japan hospital supplies market owing to the factors such as a rise in infectious diseases that require vaccinations, an increase in healthcare expenditure, and a rise in product launches in Japan. For instance, as per the NIID Japan 2022 surveillance update, 1,738 cumulative cases of tuberculosis were reported in Tokyo in 2022. As the number of infectious diseases increases, the demand for immunization rises, thereby driving the syringes and needles segment growth over the forecast period.

Furthermore, product launches, collaborations, and partnerships regarding the sale and availability of needles and syringes are anticipated to boost market growth over the forecast period. For instance, in March 2021, Terumo Corp. developed a syringe that extracts seven shots from a vial of the COVID-19 vaccine, compared to five shots using existing syringes. Furthermore, the rise in vaccinations and immunization in the studied region is anticipated to promote the growth of the syringes and needles market. For instance, according to Our World In Data October 2022 update, 95% of children under one were immunized with the BCG vaccination in Japan in 2021.

Hence, due to the infectious diseases increase and the increase in vaccination and immunization programs, the syringes and needle segment is anticipated to witness growth in the market over the forecast period.

Japan Hospital Supplies Market Competitor Analysis

The Japanese hospital supplies market is fragmented due to several companies operating globally and regionally. Japan is a developed country and has trade relations with other developed nations. As a result, it enjoys the presence of most of the global players in the Japan hospital supplies market. Moreover, some domestic Japanese companies also have a presence in the hospital supplies market. Other global players have made the Japanese market competitive for hospital supplies. Some significant players include 3M, Medtronic, Cardinal Health, Boston Scientific Corporation, and B. Braun SE, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Incidences of Communicable Diseases
    • 4.2.2 Rapid Expansion of Healthcare Infrastructure
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
    • 4.3.2 Emergence of Home Care Services
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Physical Examination Devices
    • 5.1.2 Operating Room Equipment
    • 5.1.3 Mobility Aids and Transportation Equipment
    • 5.1.4 Sterilization and Disinfectant Products
    • 5.1.5 Disposable Hospital Supplies
    • 5.1.6 Syringes and Needles
    • 5.1.7 Other Types

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 B. Braun SE
    • 6.1.3 Baxter International
    • 6.1.4 Becton Dickinson and Company
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Cardinal Health
    • 6.1.7 Medtronic
    • 6.1.8 GE Healthcare
    • 6.1.9 Johnson & Johnson
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS